These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 22691903)

  • 1. Progress in the emergency management of hereditary angioedema: focus on new treatment options in the United States.
    Bernstein JA; Moellman JJ
    Postgrad Med; 2012 May; 124(3):91-100. PubMed ID: 22691903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary angioedema therapies in the United States: movement toward an international treatment consensus.
    Riedl M
    Clin Ther; 2012 Mar; 34(3):623-30. PubMed ID: 22386830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hereditary angioedema: a review (CME).
    Bhardwaj N; Craig TJ
    Transfusion; 2014 Nov; 54(11):2989-96; quiz 2988. PubMed ID: 24735226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update on hereditary angioedema.
    Hsu D; Shaker M
    Curr Opin Pediatr; 2012 Oct; 24(5):638-46. PubMed ID: 22935756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Icatibant for the treatment of hereditary angioedema.
    Cole SW; Lundquist LM
    Ann Pharmacother; 2013 Jan; 47(1):49-55. PubMed ID: 23249729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary angioedema: management of laryngeal attacks.
    Christiansen SC; Zuraw BL
    Am J Rhinol Allergy; 2011; 25(6):379-82. PubMed ID: 22185739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evidence based therapeutic approach to hereditary and acquired angioedema.
    Bork K
    Curr Opin Allergy Clin Immunol; 2014 Aug; 14(4):354-62. PubMed ID: 24983294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis.
    Kreuz W; Martinez-Saguer I; Aygören-Pürsün E; Rusicke E; Heller C; Klingebiel T
    Transfusion; 2009 Sep; 49(9):1987-95. PubMed ID: 19497056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current management options for hereditary angioedema.
    Bork K
    Curr Allergy Asthma Rep; 2012 Aug; 12(4):273-80. PubMed ID: 22729959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Hereditary Angioedema.
    Caballero T
    J Investig Allergol Clin Immunol; 2021 Feb; 31(1):1-16. PubMed ID: 33602658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in management and treatment of hereditary angioedema.
    Sardana N; Craig TJ
    Pediatrics; 2011 Dec; 128(6):1173-80. PubMed ID: 22065270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment response after repeated administration of C1 esterase inhibitor for successive acute hereditary angioedema attacks.
    Craig TJ; Bewtra AK; Hurewitz D; Levy R; Janss G; Jacobson KW; Packer F; Bernstein JA; Rojavin MA; Machnig T; Keinecke HO; Wasserman RL
    Allergy Asthma Proc; 2012; 33(4):354-61. PubMed ID: 22856636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing hereditary angioedema patients undergoing otolaryngeal procedures.
    Bernstein JA
    Am J Rhinol Allergy; 2013; 27(6):522-7. PubMed ID: 23866957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HAE update: determining optimal patient specific therapy.
    Gower RG
    Allergy Asthma Proc; 2013; 34(1):7-12. PubMed ID: 23406928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human C1 esterase inhibitor for the treatment of hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE).
    Sabharwal G; Craig T
    Expert Rev Clin Immunol; 2015 Mar; 11(3):319-27. PubMed ID: 25669442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management and prevention of hereditary angioedema attacks.
    Lumry WR
    Am J Manag Care; 2013 Jun; 19(7 Suppl):s111-8. PubMed ID: 23844783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study.
    Moldovan D; Reshef A; Fabiani J; Kivity S; Toubi E; Shlesinger M; Triggiani M; Montinaro V; Cillari E; Realdi G; Cancian M; Visscher S; Zanichelli A; Relan A; Cicardi M
    Clin Exp Allergy; 2012 Jun; 42(6):929-35. PubMed ID: 22909164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current options for prophylactic treatment of hereditary angioedema in the United States: patient-based considerations.
    Gower RG; Lumry WR; Davis-Lorton MA; Johnston DT; Busse PJ
    Allergy Asthma Proc; 2012; 33(3):235-40. PubMed ID: 22584192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks.
    Craig TJ; Levy RJ; Wasserman RL; Bewtra AK; Hurewitz D; Obtułowicz K; Reshef A; Ritchie B; Moldovan D; Shirov T; Grivcheva-Panovska V; Kiessling PC; Keinecke HO; Bernstein JA
    J Allergy Clin Immunol; 2009 Oct; 124(4):801-8. PubMed ID: 19767078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Hereditary Angioedema Attacks with Icatibant and Recombinant C1 Inhibitor During Pregnancy.
    Hakl R; Kuklínek P; Krčmová I; Králíčková P; Freiberger T; Janků P; Vlková M; Litzman J
    J Clin Immunol; 2018 Oct; 38(7):810-815. PubMed ID: 30280305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.